Start with decisions, not available data
The dashboard should help leaders decide where intervention, investment, or escalation is needed. Each metric should have an owner, target, trend, and explanation of material variance.
Balance financial and clinical measures
Drug expense, 340B savings, charge capture, inventory, and waste should sit alongside antimicrobial stewardship, intervention activity, medication safety, and regulatory readiness.
Use a limited executive scorecard
A concise scorecard is more useful than a large collection of unprioritized metrics. Supporting detail can remain available for pharmacy management and deeper review.
Explain the story behind variance
Numbers without context can create the wrong conclusion. The dashboard should identify major drivers, corrective action, and what leadership should expect next.
BPRx can help assess current practice and build a practical improvement plan.
Request a consultation →